Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the safety, tolerability and antiviral effects of omega
interferon administered alone to omega interferon administered with ribavirin in the
treatment of subjects with chronic Hepatitis C virus (HCV) infection.
Phase:
Phase 2
Details
Lead Sponsor:
Intarcia Therapeutics
Treatments:
Interferon omega 1 Interferon Type I Interferons Ribavirin